A phase II study of pazopanib in asian patients with recurrent/metastatic nasopharyngeal carcinoma
10.1158/1078-0432.CCR-10-3409
Saved in:
Main Authors: | Lim, W.-T., Ng, Q.-S., Ivy, P., Leong, S.-S., Singh, O., Chowbay, B., Gao, F., Thng, C.H., Goh, B.-C., Tan, D.S.-W., Koh, T.S., Toh, C.-K., Tan, E.-H. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/126599 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma
by: Chia, W.-K., et al.
Published: (2014) -
Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic merkel cell carcinoma
by: Davids, M., et al.
Published: (2011) -
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H
by: Bible, K.C., et al.
Published: (2016) -
Differential cellular zinc levels in metastatic and primary nasopharyngeal carcinoma
by: Bay, B.-H., et al.
Published: (2014) -
Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
by: Lim, Chwee Ming, et al.
Published: (2022)